ms and semaglutide Semaglutide and Multiple Sclerosis: Safety and Clinical Guidance GLP-1 implant from Vivani Medical
Description
Side effects minimal
Improved blood sugar control stabilises glucose levels and reduces insulin resistance
Patients with dominant FTO risk variants (associated with higher baseline hunger signaling) typically need longer-term medication support to maintain results
[DOI] [PMC free article] [PubMed] [Google Scholar] Albericio F., Kruger H
Unlike brand-name GLP-1s, these products are not FDA-approved, so safety, purity, and effectiveness may vary
Calories are, simply put, energy for your body
